Search results for "Highlights"
NAFLD progression associated with increased mortality risk
Patients with stage F4 nonalcoholic fatty liver disease (NAFLD) have significantly increased risk for liver-related complications, type 2 diabetes, and all-cause mortality compared to those with earlier stages, an observational prospective study found.
https://gastroenterology.acponline.org/archives/2021/10/22/3.htm
22 Oct 2021
Mailed FIT screening for CRC effective, cost-effective in safety-net population
Patients at a federally qualified health center system in Central Texas who were not up to date on colorectal cancer (CRC) screening were mailed a packet containing an introductory letter, a fecal immunochemical test (FIT), easy-to-read instructions, and a postage-paid lab mailer.
https://gastroenterology.acponline.org/archives/2021/05/28/2.htm
28 May 2021
Use of PPIs may be associated with C. difficile infections
A Danish nationwide cohort study found that ongoing exposure to proton-pump inhibitors (PPIs) was associated with moderately increased community-associated Clostridioides difficile infection risk during treatment and for up to one year afterward.
https://gastroenterology.acponline.org/archives/2021/03/26/3.htm
26 Mar 2021
Failure to undergo colonoscopy after positive FIT may double risk for death from colorectal cancer
A retrospective cohort study in Italy compared 10-year cumulative incidence and mortality among patients with a positive result on a fecal immunochemical test (FIT) who completed a diagnostic colonoscopy versus those who did not.
https://gastroenterology.acponline.org/archives/2021/04/23/3.htm
23 Apr 2021
GI bleeding risks with warfarin and DOACs compared
Warfarin was associated with a similar risk of lower GI bleeding as direct oral anticoagulants (DOACs) but more than twice the rate of upper GI bleeding, which led study authors to suggest that DOACs may be preferable to warfarin in patients at high risk of upper GI bleeds.
https://gastroenterology.acponline.org/archives/2022/08/26/1.htm
26 Aug 2022
Antibody-based multitarget FIT may be more accurate than standard FIT
A multitarget fecal immunochemical test (FIT) could reduce colorectal cancer incidence and death and might be cost-effective, according to a recent validation study.
https://gastroenterology.acponline.org/archives/2021/07/23/3.htm
23 Jul 2021
Education for patients reduced upper GI endoscopies for uninvestigated dyspepsia
To reduce overuse, a Dutch trial provided a self-managed, web-based educational intervention containing information on gastric function, dyspepsia, and upper GI tract endoscopy to some patients referred for the procedure by their primary care clinicians.
https://gastroenterology.acponline.org/archives/2021/05/28/3.htm
28 May 2021
Biopsy-proven NAFLD associated with higher rates of MACE
Patients in a Swedish study whose nonalcoholic fatty liver disease (NAFLD) was confirmed on biopsy were more likely to experience incident major adverse cardiovascular events (MACE).
https://gastroenterology.acponline.org/archives/2021/09/24/2.htm
24 Sep 2021
Urgent endoscopy did not improve outcomes from acute upper GI bleeds
Thirty-day mortality was slightly lower among high-risk patients who underwent endoscopy for an acute upper GI bleed within 24 hours of a consult instead of within six hours, although the difference was not statistically significant.
https://gastroenterology.acponline.org/archives/2020/04/24/3.htm
24 Apr 2020
GI symptoms associated with better outcomes from COVID-19, new two-part study finds
SARS-CoV-2 was commonly present in the gastrointestinal tract but didn't cause inflammation there, according to a recent analysis of intestinal biopsy tissues from patients with COVID-19.
https://gastroenterology.acponline.org/archives/2021/03/26/2.htm
26 Mar 2021